We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+3.03%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1B
AUM Growth
+$23.3M
Cap. Flow
-$786K
Cap. Flow %
-0.08%
Top 10 Hldgs %
46.78%
Holding
57
New
3
Increased
22
Reduced
17
Closed
1

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$16.4M
2
NVO
Novo Nordisk
NVO
+$2.58M
3
MMM icon
3M
MMM
+$2.33M
4
JNJ icon
Johnson & Johnson
JNJ
+$1.69M
5
NKE icon
Nike
NKE
+$1.55M

Sector Composition

Rank Sector Weight
1 Technology 28.29%
2 Healthcare 19.73%
3 Consumer Staples 17.2%
4 Industrials 16.48%
5 Consumer Discretionary 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.76T
$57.5M 5.72%
1,378,006
+32,142
+2% +$1.3M
ORCL icon
2
Oracle
ORCL
$435B
$55.5M 5.53%
1,369,612
+37,587
+3% +$1.55M
MMM icon
3
3M
MMM
$93.9B
$51.4M 5.12%
429,528
-19,849
-4% -$2.33M
MDT icon
4
Medtronic
MDT
$114B
$48.6M 4.84%
762,180
+3,872
+0.5% +$235K
RTX icon
5
RTX Corp
RTX
$302B
$45M 4.48%
619,384
+159
+0% +$11.7K
CSCO icon
6
Cisco
CSCO
$483B
$44.8M 4.46%
1,803,687
+38,199
+2% +$910K
OMC icon
7
Omnicom Group
OMC
$23.2B
$42.8M 4.26%
600,385
-15,270
-2% -$1.06M
MCD icon
8
McDonald's
MCD
$194B
$41.8M 4.16%
414,581
+11,979
+3% +$1.21M
WMT icon
9
Walmart Inc
WMT
$897B
$41.6M 4.14%
1,663,767
+47,973
+3% +$1.23M
KO icon
10
Coca-Cola
KO
$374B
$41M 4.08%
968,191
-17,875
-2% -$725K
PG icon
11
Procter & Gamble
PG
$340B
$40.6M 4.04%
516,801
+14,950
+3% +$1.21M
BDX icon
12
Becton Dickinson
BDX
$48.9B
$40.4M 4.02%
349,731
-7,395
-2% -$838K
IBM icon
13
IBM
IBM
$223B
$38.3M 3.81%
220,868
+8,491
+4% +$1.53M
JNJ icon
14
Johnson & Johnson
JNJ
$631B
$36.4M 3.62%
347,941
-16,694
-5% -$1.69M
NVO
15
Novo Nordisk
NVO
$211B
$35.8M 3.57%
1,550,850
-116,720
-7% -$2.58M
CHRW icon
16
C.H. Robinson
CHRW
$17.3B
$32M 3.19%
502,263
+50,810
+11% +$2.99M
AAPL icon
17
Apple
AAPL
$4.5T
$29.4M 2.93%
1,266,216
-336
-0% -$7.15K
NKE icon
18
Nike
NKE
$62.5B
$29.2M 2.91%
753,602
-41,570
-5% -$1.55M
ACN icon
19
Accenture
ACN
$109B
$26.1M 2.6%
322,580
+42,400
+15% +$3.4M
VAR
20
DELISTED
Varian Medical Systems, Inc.
VAR
$25.4M 2.52%
347,849
+51,248
+17% +$3.68M
BRK.B icon
21
Berkshire Hathaway Class B
BRK.B
$1.14T
$23.1M 2.3%
182,511
+3,045
+2% +$385K
GD icon
22
General Dynamics
GD
$107B
$20.4M 2.03%
174,706
-10,143
-5% -$1.15M
SYK icon
23
Stryker
SYK
$133B
$17.5M 1.75%
207,990
-8,895
-4% -$726K
ADP icon
24
Automatic Data Processing
ADP
$109B
$16.3M 1.62%
233,697
-15,147
-6% -$1.03M
PEP icon
25
PepsiCo
PEP
$188B
$16.1M 1.6%
180,326
+16,287
+10% +$1.41M

Similar funds

Saratoga Research & Investment Management's Q2 2014 Portfolio in Review

As of Q2 2014, Saratoga Research & Investment Management held 57 positions worth $1B, up 2.4% from $981M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Saratoga Research & Investment Management's Q2 2014 filing shows 3 new, 22 increased, 17 reduced and 1 closed positions. Its largest new stake was GE Aerospace: 2,066 shares worth $260K. The largest sale was Abbott, an estimated $16.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Saratoga Research & Investment Management's largest Q2 2014 buy was GE Aerospace: 2,066 shares worth $260K.
  • Saratoga Research & Investment Management added most to Varian Medical Systems, Inc. in Q2 2014, an estimated $3.68M increase.
  • Saratoga Research & Investment Management's biggest Q2 2014 reduction was Novo Nordisk, cutting an estimated $2.58M.
  • Saratoga Research & Investment Management fully exited Abbott in Q2 2014, selling an estimated $16.4M.
  • Saratoga Research & Investment Management's ten largest holdings make up 47% of its $1B portfolio in Q2 2014.
  • Saratoga Research & Investment Management opened 3 new positions and closed 1 in Q2 2014.
  • Saratoga Research & Investment Management's portfolio value rose 2.4% quarter-over-quarter to $1B.

Based on Saratoga Research & Investment Management's 13F filing for Q2 2014, filed 6 Aug 2014.